IMCC Overview

IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.

Wall Street analysts forecast IMCC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMCC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

IM Cannabis Corp revenue for the last quarter amounts to 15.68M USD, increased 17.62

IM Cannabis Corp. EPS for the last quarter amounts to -1.33 USD, increased 259.46

IM Cannabis Corp (IMCC) has 44 emplpoyees as of April 21 2026.

Today IMCC has the market capitalization of 2.55M USD.